| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ceftriaxone | FAERS: 3 | US FAERS | |
| 2 | rucaparib | FAERS: 2 | US FAERS | |
| 3 | Buprenorphine | FAERS: 1 | US FAERS | |
| 4 | Dabigatran | FAERS: 1 | US FAERS | |
| 5 | Lapatinib | FAERS: 1 | US FAERS | |
| 6 | Lisdexamfetamine Dimesylate | FAERS: 1 | US FAERS | |
| 7 | Modafinil | FAERS: 1 | US FAERS | |
| 8 | Norgestrel | FAERS: 1 | US FAERS | |
| 9 | Paclitaxel | FAERS: 1 | US FAERS | |
| 10 | Warfarin | FAERS: 1 | US FAERS | |
| 11 | acetaminophen, codeine drug combination | FAERS: 1 | US FAERS | |
| 12 | atovaquone, proguanil drug combination | FAERS: 1 | US FAERS | |
| 13 | Lamotrigine | OFFSIDES | ||
| 14 | Nitrates | OFFSIDES | ||
| 15 | Ribavirin | OFFSIDES | ||
| 16 | Temozolomide | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.